Neuramis is Medytox Inc.'s premium hyaluronic acid dermal filler range, developed by the same Korean pharmaceutical company that produces Innotox and Metox botulinum toxins. The Neuramis range uses Medytox's proprietary SHAPE technology, distinguishing it from other Korean and Western fillers through its uniquely smooth, homogeneous gel characteristics.
SHAPE Technology
SHAPE (Smooth Hyaluronzuur Particle Engineering) is Medytox's cross-linking approach that creates a tightly controlled, monophasic HA network. The result is a gel with excellent extrusion force through fine needles, consistent flow properties, and appropriate cohesivity for the intended tissue level.
Neuramis Deep: Specifications and Applications
Neuramis Deep (24mg/ml, 1ml) with lidocaine 0.3% is designed for deep dermis and subcutaneous placement. Indicated for:
- Moderate-to-severe nasolabial folds
- Marionette lines
- Cheek augmentation and contouring
- Chin projection
- Jaw definition
Expected duration: 12–18 months. CE marked.
Clinical Technique Considerations
The smooth flow properties of Neuramis Deep are particularly suited to linear threading and fan techniques. The gel behaves predictably during application, with consistent spread and minimal product migration. The lidocaine formulation provides adequate local anaesthesia during application.